Phenotype measures set

ID, description, units MPD:52427   T cells, percent viability   [%]
doxorubicin study
Measures • dose [µM]:    • control    • 0.046    • 0.137    • 1.235    • 11.1    • 100
Data set, strains Wiltshire4   inbred w/CC7   35 strains     sex: m     age: 10wks
Procedure immune cell quantification
Comparisoncontrol group as well as two or more dosage groups
Ontology mappings



Dimensions Width:  ×  Height: px
Values
Graph Type
Plot Options
Download Plot   

Wiltshire4 - T cells, percent viability

Female

Male



  RM-ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
dose 5 98867.4594 19773.4919 355.6268 < 0.0001
strain 33 51210.4266 1551.8311 27.9097 < 0.0001
dose:strain 165 88833.3575 538.384 9.6829 < 0.0001
Residuals 593 32971.8729 55.6018

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelNo.
strains
SexAge
Wiltshire4 52427 immune cell quantification doxorubicin T cells, percent viability   [%]   control   Tcells_Dox_ctrl inbred w/CC7 35 m 10wks
Wiltshire4 52428 immune cell quantification doxorubicin T cells, percent viability   [%]   dose: 0.046 µM   Tcells_Dox_A inbred w/CC7 35 m 10wks
Wiltshire4 52429 immune cell quantification doxorubicin T cells, percent viability   [%]   dose: 0.137 µM   Tcells_Dox_B inbred w/CC7 35 m 10wks
Wiltshire4 52430 immune cell quantification doxorubicin T cells, percent viability   [%]   dose: 1.235 µM   Tcells_Dox_C inbred w/CC7 35 m 10wks
Wiltshire4 52431 immune cell quantification doxorubicin T cells, percent viability   [%]   dose: 11.1 µM   Tcells_Dox_D inbred w/CC7 35 m 10wks
Wiltshire4 52432 immune cell quantification doxorubicin T cells, percent viability   [%]   dose: 100 µM   Tcells_Dox_E inbred w/CC7 35 m 10wks